• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694

tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate (CAS No. 236406-38-5): An Overview

tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate (CAS No. 236406-38-5) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as TBHEHP, is a piperidine derivative characterized by its unique structural features, including a tert-butyl group, a hydroxyethyl substituent, and a hydroxymethyl group. These functional groups contribute to its chemical stability and reactivity, making it an attractive candidate for various synthetic transformations and biological studies.

The chemical structure of tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate is represented by the formula C₁₃H₂₅NO₄. The presence of multiple hydroxyl groups imparts significant solubility in polar solvents, which is crucial for its use in solution-phase reactions and biological assays. The tert-butyl group provides steric protection, enhancing the compound's stability under various reaction conditions.

In recent years, TBHEHP has gained attention due to its potential in the development of novel therapeutic agents. One of the key areas of research involves its use as an intermediate in the synthesis of bioactive molecules. For instance, a study published in the Journal of Medicinal Chemistry highlighted the role of TBHEHP in the synthesis of selective serotonin reuptake inhibitors (SSRIs), which are widely used in the treatment of depression and anxiety disorders. The unique structural features of TBHEHP enable it to serve as a building block for these complex molecules, facilitating the optimization of their pharmacological properties.

Beyond its applications in drug synthesis, tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate has also been explored for its potential biological activities. Research conducted at the University of California, Los Angeles (UCLA) demonstrated that TBHEHP exhibits moderate anti-inflammatory properties. In vitro studies showed that it can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, suggesting its potential as a lead compound for developing anti-inflammatory drugs.

The synthesis of tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate typically involves multi-step processes that require careful control over reaction conditions to ensure high yields and purity. A common synthetic route involves the reaction of tert-butyl piperidine carboxylate with appropriate alcohols and aldehydes under catalytic conditions. Advances in catalysis and green chemistry have led to more efficient and environmentally friendly methods for producing TBHEHP, making it more accessible for large-scale applications.

In addition to its medicinal applications, TBHEHP has found use in other areas of chemical research. For example, it has been employed as a chiral auxiliary in asymmetric synthesis, where its ability to control stereochemistry is crucial for producing enantiomerically pure compounds. This property is particularly valuable in the pharmaceutical industry, where enantiomeric purity can significantly impact drug efficacy and safety.

The safety profile of tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate is an important consideration for both laboratory use and industrial applications. While it is generally considered safe when handled properly, standard precautions should be taken to avoid skin contact and inhalation. Proper storage conditions, such as maintaining a dry environment and avoiding exposure to high temperatures, are essential to preserve its stability and effectiveness.

In conclusion, tert-Butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)piperidine-1-carboxylate (CAS No. 236406-38-5) is a multifaceted compound with diverse applications in medicinal chemistry, pharmaceutical research, and other areas of chemical science. Its unique structural features and versatile reactivity make it an invaluable tool for scientists working on the development of new therapeutic agents and advanced materials. As research continues to uncover new possibilities for this compound, it is likely to play an increasingly important role in future scientific advancements.

• 75844-69-8(tert-butyl piperidine-1-carboxylate)
• 123855-51-6(tert-butyl 4-(hydroxymethyl)piperidine-1-carboxylate)
• 162167-97-7(Tert-butyl 3-(aminomethyl)piperidine-1-carboxylate)
• 180307-56-6(Tert-butyl 4-vinylpiperidine-1-carboxylate)
• 89151-44-0(tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate)
• 144222-22-0(tert-butyl 4-(aminomethyl)piperidine-1-carboxylate)
• 146667-84-7(Tert-butyl 3-(2-hydroxyethyl)piperidine-1-carboxylate)
• 114214-69-6(1-Boc-3-(Hydroxymethyl)pyrrolidine)
• 116574-71-1(Tert-butyl 3-(hydroxymethyl)piperidine-1-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)